Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 177, Issue 20, Pages 4595-4600
Publisher
Wiley
Online
2020-09-21
DOI
10.1111/bph.15212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
- (2020) Simon McArthur et al. JOURNAL OF CLINICAL INVESTIGATION
- Structural basis of ligand binding modes at the human formyl peptide receptor 2
- (2020) Tong Chen et al. Nature Communications
- The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer
- (2020) Weiwei Liang et al. Frontiers in Endocrinology
- Dual modulation of formyl peptide receptor 2 by aspirin‐triggered lipoxin contributes to its anti‐inflammatory activity
- (2020) Yunjun Ge et al. FASEB JOURNAL
- Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
- (2020) Yoshikazu Asahina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization
- (2019) Xiaofang Chen et al. DIABETES
- Illuminating G-Protein-Coupling Selectivity of GPCRs
- (2019) Asuka Inoue et al. CELL
- Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair
- (2019) Bartolo Ferraro et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
- (2018) E. P. Brennan et al. DIABETES
- Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
- (2018) Monica de Gaetano et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
- (2018) Monica de Gaetano et al. Frontiers in Pharmacology
- The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1
- (2017) Kátia M. Lima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune resolution mechanisms in inflammatory arthritis
- (2017) Mauro Perretti et al. Nature Reviews Rheumatology
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
- (2017) Cheng Xue Qin et al. Nature Communications
- Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway
- (2017) Giorgio Mottola et al. PLoS One
- Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949
- (2016) Anna K. Stalder et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition
- (2016) Benedict Wu et al. FASEB JOURNAL
- Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells
- (2016) Soon Chul Heo et al. STEM CELLS
- Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
- (2015) Emma Börgeson et al. Cell Metabolism
- Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
- (2015) Mauro Perretti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
- (2014) Irene Locatelli et al. HEPATOLOGY
- FPR2/ALXR Agonists and the Resolution of Inflammation
- (2014) Olivier Corminboeuf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
- (2014) Thomas Gobbetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AMPKα1 Regulates Macrophage Skewing at the Time of Resolution of Inflammation during Skeletal Muscle Regeneration
- (2013) Rémi Mounier et al. Cell Metabolism
- Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses
- (2010) K. Chen et al. JOURNAL OF IMMUNOLOGY
- Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
- (2010) Neil Dufton et al. JOURNAL OF IMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now